Exclusive

Publication

Byline

Location

US Patent Issued to BIOVIE on July 21 for "Methods of treating disease with Terlipressin" (Pennsylvania, Virginia Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,756, issued on July 21, was assigned to BIOVIE INC. (Reno, Nev.). "Methods of treating disease with Terlipressin" was invented by Penelope ... Read More


US Patent Issued to GEORGETOWN UNIVERSITY on July 21 for "Method to increase systemic blood pressure in shock" (District Of Columbia Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,757, issued on July 21, was assigned to GEORGETOWN UNIVERSITY (Washington). "Method to increase systemic blood pressure in shock" was inven... Read More


US Patent Issued to NaNotics on July 21 for "Compositions and methods for inhibiting the biological activity of soluble biomolecules" (California Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,758, issued on July 21, was assigned to NaNotics LLC (Mill Valley, Calif.). "Compositions and methods for inhibiting the biological activit... Read More


US Patent Issued to YALE UNIVERSITY on July 21 for "Interleukin-18 variants and methods of use" (Connecticut Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,759, issued on July 21, was assigned to YALE UNIVERSITY. "Interleukin-18 variants and methods of use" was invented by Aaron Ring (New Haven... Read More


US Patent Issued to Synthekine on July 21 for "IL2 muteins" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,760, issued on July 21, was assigned to Synthekine Inc. (Menlo Park, Calif.). "IL2 muteins" was invented by Jan Emmerich (Menlo Park, Calif... Read More


US Patent Issued to Emory University on July 21 for "VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease" (Georgia Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,761, issued on July 21, was assigned to Emory University (Atlanta). "VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell m... Read More


US Patent Issued to JCR Pharmaceuticals on July 21 for "Aqueous pharmaceutical composition containing fusion protein of serum albumin and growth hormone" (Japanese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,762, issued on July 21, was assigned to JCR Pharmaceuticals Co. Ltd. (Ashiya, Japan). "Aqueous pharmaceutical composition containing fusion... Read More


US Patent Issued to Alexion Pharmaceuticals on July 21 for "Methods for treating intracranial hemorrhage and assessing efficacy" (California Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,763, issued on July 21, was assigned to Alexion Pharmaceuticals Inc. (Boston). "Methods for treating intracranial hemorrhage and assessing ... Read More


US Patent Issued to The Trustees of the University of Pennsylvania, Icahn School of Medicine at Mount Sinai on July 21 for "Universal influenza vaccine using nucleoside-modified mRNA" (Pennsylvania, New York Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,764, issued on July 21, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and Icahn School of Medicine at Mount ... Read More


US Patent Issued to UNIVERZITA PALACKEHO V OLOMOUCI, NEXIUM, S.R.O. on July 21 for "Polypeptides mimicking MPER and V3-loop HIV-1 Env glycoprotein epitopes" (Czech Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,765, issued on July 21, was assigned to UNIVERZITA PALACKEHO V OLOMOUCI (Olomouc, Czech Republic) and NEXIUM, S.R.O. (Chlumec nad Cidlinou, ... Read More